Home
About
Product
News
Honor
Contact
Purchasing
Company News
Industry trends
Purchasing information
Today, the company announced that it signed the Third Amendment with the existing shareholders and related parties of India Gland, adjusting the transaction to: the company invested no more than US $1091.3 million to acquire about 74% of Gland's equity, including the contingent consideration paid for the listing and sale of Gland Enoxaparin in the United States, which did not exceed US $25 million. The termination date of this transaction is extended to October 3, 2017.
2017-09-20
September 24 is World Heart Day. The eternal theme of World Heart Day is "Healthy Heart, Happy Life". As we all know, the heart is the only organ that cannot rest for a moment. Coronary heart disease, arrhythmia, heart failure, rheumatic heart disease, cardiomyopathy and other cardiovascular diseases seriously threaten human health, while hypertension, hyperlipidemia, hyperglycemia are the main inducements leading to stroke, myocardial infarction and peripheral vascular disease.
2017-10-09
Heparin Sodium 2026: Pharmaceutical Grade Manufacturer, Quality Specs & Sourcing Guide
2026-11-13
Aprotinin Raw Material 2026: Uses, Quality Standards & Sourcing Guide
2026-11-08
Aprotinin Manufacturer 2026: Definition, Uses, Quality Specs, Sourcing Guide
2026-11-03
Aprotinin: GMP-Grade Pharmaceutical Raw Material for Global Clinical Supply 2026
2026-10-29
Aprotinin 2026 Raw Material Guide: Trusted Manufacturer & Supplier | RunquanKang
2026-10-24
Exploring the Sweet Side of Anhydrous Sodium Saccharin in Various Industries
2025-12-29